mRNA Cancer Vaccines and Therapeutics Market

mRNA Cancer Vaccines and Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

# Pages:

145

Base Year:

2022

Oct - 2024

Format:

Report Code:

VMR-1408

Segments Covered

By Application Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
By End User Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 54.99 Billion
Revenue 2030:	USD 193.14 Billion
Revenue CAGR (2023 - 2030):	17.00%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. Global mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. Global mRNA Cancer Vaccines and Therapeutics Market - by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. Global mRNA Cancer Vaccines and Therapeutics Market - by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. Global mRNA Cancer Vaccines and Therapeutics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. North America mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. North America mRNA Cancer Vaccines and Therapeutics Market, by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. North America mRNA Cancer Vaccines and Therapeutics Market, by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. North America mRNA Cancer Vaccines and Therapeutics Market, by Country
  1. U.S.
    1. U.S. mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. U.S. mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  2. Canada
    1. Canada mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Canada mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  3. Mexico
    1. Mexico mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Mexico mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
Europe mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. Europe mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. Europe mRNA Cancer Vaccines and Therapeutics Market, by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. Europe mRNA Cancer Vaccines and Therapeutics Market, by Country
  1. Germany
    1. Germany mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Germany mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  2. UK
    1. UK Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. UK Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  3. France
    1. France mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. France mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  4. Spain
    1. Spain mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Spain mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  5. Italy
    1. Italy mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Italy mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  6. BENELUX
    1. BENELUX mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. BENELUX mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  7. Rest of Europe
    1. Rest Of Europe mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Rest Of Europe mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
Asia Pacific mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Country
  1. China
    1. China mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. China mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  2. Japan
    1. Japan mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Japan mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  3. India
    1. India mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. India mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  4. South Korea
    1. South Korea mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. South Korea mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  5. South East Asia
    1. South East Asia mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. South East Asia mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
Latin America mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. Latin America mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. Latin America mRNA Cancer Vaccines and Therapeutics Market, by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. Latin America mRNA Cancer Vaccines and Therapeutics Market, by Country
  1. Brazil
    1. Brazil mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Brazil mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  2. Argentina
    1. Argentina mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Argentina mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  3. Rest of Latin America
    1. Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
  1. By Adeno Carcinomas
  2. By Mucinous Carcinomas
  3. By Adenosquamous Carcinomas
4. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by End User
  1. By Hospitals & Clinics
  2. By Ambulatory Surgical Centers
  3. By Research Institutes
  4. By Others
5. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Country
  1. GCC Countries
    1. GCC Countries mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. GCC Countries mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  2. South Africa
    1. South Africa mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. South Africa mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, By Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    2. Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, By End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Moderna Therapeutics (US)
2. eTheRNA (Belgium)
3. BioNTech (Germany)
4. CureVac (Netherlands)
5. In-Cell-Art (France)
6. Translate Bio (US)
7. Tiba Biotechnology (US)
8. Argos Therapeutics (US)
9. Sangamo Therapeutics (US)
10. and Ethris (Germany).
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 28-Mar-2022

mRNA Cancer Vaccines and Therapeutics Market to Reach Valuation of USD 108.94 Billion by 2028 - Rising Cases of Cancer Patients is expected to drive the mRNA Cancer Vaccines and Therapeutics Market

FAQ

Frequently Asked Question

What is the global demand for mRNA Cancer Vaccines and Therapeutics in terms of revenue?

The global mRNA Cancer Vaccines and Therapeutics valued at USD 54.99 Billion in 2022 and is expected to reach USD 193.14 Billion in 2030 growing at a CAGR of 17.00%.

Which are the prominent players in the market?

The prominent players in the market are Moderna Therapeutics (US), eTheRNA (Belgium), BioNTech (Germany), CureVac (Netherlands), In-Cell-Art (France), Translate Bio (US), Tiba Biotechnology (US), Argos Therapeutics (US), Sangamo Therapeutics (US), and Ethris (Germany)..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 17.00% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the mRNA Cancer Vaccines and Therapeutics include
- High Growth Prospects in Emerging Markets

Which region accounted for the largest share in the market?

North America was the leading regional segment of the mRNA Cancer Vaccines and Therapeutics in 2022.

mRNA Cancer Vaccines and Therapeutics Market

mRNA Cancer Vaccines and Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for mRNA Cancer Vaccines and Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

mRNA Cancer Vaccines and Therapeutics Market

mRNA Cancer Vaccines and Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for mRNA Cancer Vaccines and Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for mRNA Cancer Vaccines and Therapeutics Market

Vantage Point Interactive Dashboard